IGEN (IGEN) Stock Price & Analysis
IGEN (IGEN) rose 0.00% to USD 0 as of June 10, 2026 at 04:59 UTC, according to Nexqual real-time market data.
IGEN last closed at USD 0; the session ranged USD 0–0 on volume of 770,001 shares. Market capitalization is $323,460, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:59 UTC.
Key Statistics (as of June 10, 2026 at 04:59 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 770,001 shares |
| Market Cap | $323,460 |
| Exchange | PNK |
Technical Analysis (IGEN)
Nexqual's technical model rates IGEN "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 04:59 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (IGEN)
Wall Street analysts rate IGEN "None", per Nexqual as of June 10, 2026 at 04:59 UTC.
| Consensus Rating | None |
|---|
Earnings (IGEN)
Source: Nexqual, June 10, 2026 at 04:59 UTC.
Financials & Fundamentals (IGEN)
| Total Revenue | $179,506 |
|---|---|
| Revenue Growth (YoY) | -63.60% |
| Gross Margin | +29.89% |
| Operating Margin | -156.49% |
| Profit Margin | +0.00% |
| Current Ratio | 0.03 |
| Total Debt | $944,449 |
| Free Cash Flow | $-289,849 |
Source: Nexqual, June 10, 2026 at 04:59 UTC.
Financial Health Score (IGEN)
Nexqual rates IGEN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:59 UTC.
| Growth | Critical — Revenue -64% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — No data |
| Cash Flow | Weak — FCF negative: -$290K, burning cash |
| Efficiency | Mixed — No data |
Ownership (IGEN)
| Insider Ownership | +5.27% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 3.23B |
| Float | 3.05B |
Source: Nexqual, June 10, 2026 at 04:59 UTC.
Leadership (IGEN)
IGEN is led by Neil Gene Chan (age 62), CEO, CFO & Director, per Nexqual as of June 10, 2026 at 04:59 UTC.
| CEO, CFO & Director | Neil Gene Chan (age 62) |
|---|---|
| COO & Director | Abel Israel Sierra (age 52) |
| Chief Technology Officer | Juan Ignacio Avila Diaz Rubin |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TPTW | TPT Global Tech, Inc. | USD 0 | ▲ 0% |
| FONU | FONU2 INC | USD 0 | ▲ 0% |
| ILST | International Star, Inc. | USD 0 | ▲ 0% |
| PACV | Pacific Ventures Group Inc. | USD 0 | ▲ 0% |
| BRBL | BREWBILT BREWING CO | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:59 UTC. This page is informational and not investment advice.